Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Temozolomide
Matrix: | Human Plasma |
Assay Range: | 100 - 20,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Temozolomide
Matrix: | Human Plasma |
Assay Range: | 0.0200 - 20.0 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Temozolomide
Matrix: | Human Plasma |
Assay Range: | 50 - 16,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Tenofovir (TFV)
Matrix: | Human Plasma |
Assay Range: | 0.3 - 25 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Tenofovir Alafenamide (TAF)
Matrix: | Human Plasma |
Assay Range: | 2 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Testosterone
Matrix: | Human Plasma |
Assay Range: | 0.1 - 200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Sodium EDTAHeparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Testosterone
Matrix: | Human Serum |
Assay Range: | 0.500 - 50.0 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Testosterone
Matrix: | Human Plasma |
Assay Range: | 0.1 - 200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Testosterone
Matrix: | Dog Plasma |
Assay Range: | 0.2 - 16 ng/mL |
Sample Volume: | 0.6 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Testosterone
Matrix: | Human Serum |
Assay Range: | 0.05 - 25.0 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Testosterone
Matrix: | Human Plasma |
Assay Range: | 0.1 - 200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Sodium EDTAHeparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Hormone |
Classification: | Biochemical Biomarkers |
Testosterone (bioavailable)
Matrix: | Human Serum |
Assay Range: | 0.100 - 25.0 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Tetrabenazinea-dihydrotetrabenazineb-dihydrotetrabenazine
Matrix: | Human Plasma |
Assay Range: | 0.1 - 50 ng/mL 0.5 - 250 ng/mL0.5 - 250 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | CNS and Huntington's Disease |
Classification: | Drug Assays |
Theophylline
Matrix: | Human Plasma |
Assay Range: | 0.100 - 20.0 µg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | HPLC-UV |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Respiratory |
Classification: | Drug Assays |
Theophylline
Matrix: | Human Urine |
Assay Range: | 0.100 - 50.0 µg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | HPLC-UV |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Respiratory |
Classification: | Drug Assays |
Tinidazole
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Tiotropium
Matrix: | Human Plasma |
Assay Range: | 0.100 - 50.0 pg/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | NaF/K2EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Respiratory |
Classification: | Drug Assays |
Tiotropium
Matrix: | Human Plasma |
Assay Range: | 0.100 - 50.0 pg/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | NaF/K2EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Tipranavir (TPV)
Matrix: | Human Plasma |
Assay Range: | 0.5 - 112.5 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Tizanidine
Matrix: | Human Plasma |
Assay Range: | 1 - 500 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Muscle Relaxant |
Classification: | Drug Assays |
TNF-α
Matrix: | Human Plasma |
Assay Range: | 16 - 1,000 pg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Citrate EDTA Heparin |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
TNF-α
Matrix: | Human Serum |
Assay Range: | 16 - 1,000 pg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
TNF-α
Matrix: | Human Serum |
Assay Range: | 20 - 4,000 pg/mL |
Sample Volume: | 0.06 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | Luminex |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
TNF-α
Matrix: | Human Whole Blood Supernatant |
Assay Range: | 6.2 - 459 pg/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
TNF-α High Sensitivity
Matrix: | Human Plasma |
Assay Range: | 0.7 - 40,000 pg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -20 |
Platform: | ECL (MSD) |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT